20 AIDX
NASDAQ AIDX
$0.27 +0.01 (+3.41%)
As of: Oct 20, 2026 · 3:59 PM EDT

20 (AIDX) Research & Development (2025 - 2026)

Updated

20 (AIDX) posted Research & Development of $257,632 for Q2 2026, up 32.7% from $194,124 a year earlier and up 67.9% from the prior quarter.

Analysis

20 (AIDX) Research & Development (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at 20 was $742,069; for FY2025, it was $592,569, down 53.0% from FY2024.

  • In prior years, 20's Research & Development was $1.26 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 HCA Healthcare 102.50 Bn 98.51 Bn - -
2 Natera 58.05 Bn 53.74 Bn 485.19 Mn 228.07 Mn
3 Labcorp Holdings 26.39 Bn 24.13 Bn 1.11 Bn -
4 Quest Diagnostics 26.28 Bn 24.41 Bn 1.03 Bn -
5 Tenet Healthcare 22.71 Bn 11.72 Bn - -
6 Guardant Health 21.59 Bn 17.65 Bn 219.03 Mn 96.53 Mn
7 BrightSpring Health Services 12.87 Bn 11.21 Bn 492.75 Mn -
8 Fresenius Medical Care AG 12.49 Bn 4.44 Bn 1.52 Bn 46.06 Mn
9 Encompass Health 12.04 Bn 11.70 Bn - -
10 20 2.84 Mn -8.73 Mn 304,727.00 257,632.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 257,632.00
Mar 31, 2026 153,482.00
Jun 30, 2025 194,124.00
Mar 31, 2025 136,831.00
API Access

20 Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=AIDX&period=max&api_key=YOUR_API_KEY